in the beta blocker heart attack trial ( bhat ) , 3837 patients were randomized to propranolol ( 180-240 mg/day ) or placebo 5-21 days after a documented myocardial infarction and were followed in a double blind manner for a mean period of 25 months .
C0033497
propranolol
C0027051
myocardial